Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center

@article{Schaad2022PointofcareLU,
  title={Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center},
  author={Simon M. Schaad and T Brahier and Mary-Anne Hartley and Jean-Baptiste Cordonnier and Luca Bosso and Tanguy Espejo and Olivier Pantet and Olivier Hugli and Pierre-Nicolas Carron and Jean-Yves Meuwly and No{\'e}mie Boillat-Blanco},
  journal={BMJ Open},
  year={2022},
  volume={12}
}
Objectives Early identification of SARS-CoV-2 infection is important to guide quarantine and reduce transmission. This study evaluates the diagnostic performance of lung ultrasound (LUS), an affordable, consumable-free point-of-care tool, for COVID-19 screening. Design, setting and participants This prospective observational cohort included adults presenting with cough and/or dyspnoea at a SARS-CoV-2 screening centre of Lausanne University Hospital between 31 March and 8 May 2020. Interventions… 
1 Citations
Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study
TLDR
The symptoms and predictors of the post-COVID-19 syndrome need further characterization as this condition places a significant burden on society.

References

SHOWING 1-10 OF 46 REFERENCES
Point-of-care Lung Ultrasound Is More Sensitive than Chest Radiograph for Evaluation of COVID-19
TLDR
LUS was found to have a higher sensitivity than CXR for the evaluation of COVID-19, particularly where viral testing is not available or restricted and future directions would include defining how to incorporate LUS into clinical management and its role in screening lower-risk populations.
Lung ultrasonography for risk stratification in patients with COVID-19: a prospective observational cohort study
TLDR
Systematic LUS has potential as a reliable, cheap and easy-to-use triage tool for the early risk stratification in COVID-19 patients presenting in EDs.
Lung Ultrasonography in Ruling Out COVID-19 Among Health Care Workers in Two Italian Emergency Departments: A Multicenter Study
TLDR
LUS has a high enough NPV for excluding a COVID-19-related pneumonia in a cohort of health care employees who were exposed to the SARS-CoV2 virus.
Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study
TLDR
Combining LUS patterns of probability with clinical phenotypes at presentation can rapidly identify those patients with or without COVID-19 pneumonia at bedside, and could support and expedite patients’ management during a pandemic surge.
Lung ultrasound predicts clinical course and outcomes in COVID-19 patients
TLDR
Routine use of LUS may guide patients’ management strategies, as well as resource allocation in case of surge capacity, and is a strong predictor of mortality.
The role of lung ultrasound as a frontline diagnostic tool in the era of COVID-19 outbreak
TLDR
Lung POCUS is a sensitive first-line screening tool for ED patients presenting with symptoms suggestive of SARS-CoV-2 infection in a high-prevalence setting and is evaluated using sensitivity, specificity, and positive and negative predictive value.
The association of lung ultrasound images with COVID‐19 infection in an emergency room cohort
TLDR
A predictive model for COVID‐19 diagnosis based on lung ultrasound and clinical features that may facilitate triage of patients with suspected CO VID‐19 infection admitted to the emergency room is developed.
Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms
TLDR
The predominant lung changes were GGO and reticular alteration, while consolidation was less frequent, and the typical distribution pattern was bilateral, peripheral, or both peripheral and central and involved predominantly the lower and middle fields.
THORACIC IMAGING TESTS FOR THE DIAGNOSIS OF COVID-19
TLDR
The diagnostic accuracy of chest imaging (computed tomography, X-ray and ultrasound) in people with suspected or confirmed COVID-19 disease was determined and uncertainty of the accuracy estimates was presented using 95% confidence intervals (CIs).
...
...